CarfilzoMib-d8

Uses

Carfilzomib-d8, is the labeled analogue of Carfilzomib (C183460), which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.

Uses

CarfilzoMib-d8 is a labeled carfilzomib, intended for use as an internal standard for the quantification of Carfilzomib by GC- or LC-mass spectrometry.